Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

Por Tesch, Greg H., Young, Morag J.
Publicado no Front Pharmacol (2017)

Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628

Por Ma, Frank Y., Han, Yingjie, Nikolic-Paterson, David J., Kolkhof, Peter, Tesch, Greg H.
Publicado no PLoS One (2015)

Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease

Por Huang, Louis L., Nikolic-Paterson, David J., Han, Yingjie, Ozols, Elyce, Ma, Frank Y., Young, Morag J., Tesch, Greg H.
Publicado em 2014

Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat

Por Ramessur Chandran, Sharmila, Tesch, Greg H, Han, Yingjie, Woodman, Naomi, Mulley, William R, Kanellis, John, Blease, Kate, Ma, Frank Y, Nikolic-Paterson, David J
Publicado no Int J Exp Pathol (2015)

Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor

Por Zhang, Chao, Ibrahim, Prabha N., Zhang, Jiazhong, Burton, Elizabeth A., Habets, Gaston, Zhang, Ying, Powell, Ben, West, Brian L., Matusow, Bernice, Tsang, Garson, Shellooe, Rafe, Carias, Heidi, Nguyen, Hoa, Marimuthu, Adhirai, Zhang, Kam Y. J., Oh, Angela, Bremer, Ryan, Hurt, Clarence R., Artis, Dean R., Wu, Guoxian, Nespi, Marika, Spevak, Wayne, Lin, Paul, Nolop, Keith, Hirth, Peter, Tesch, Greg H., Bollag, Gideon
Publicado em 2013